Business
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n\n PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB:BIEI) (\"the Company\") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company developments.\n Premier Biomedical consists of two groups: The Biologics Group deals fundamentally with the treatment of disease, both extra-corporeally and via immunotherapy, while the second group, Pain Relief Meds.Com, has developed hemp oil CBD topical pain relief products (www.painreliefmeds.com). According to Hartman, the pain relief team has developed stronger formulas for their oil-based roll-ons, sprays, and ointments that contain one of the highest levels of CBD in the industry. These will be released at the Sorinex Summer Strong Event on May 18-20, 2018. Hartman also addressed the concern over recent news about the company’s upcoming reverse split. Developments within the regulatory agencies are forcing sub-penny stocks to be increasingly difficult to be sold. “We’ve thought about it, and we’ve researched it through experts who have told us that a reverse split could be a great thing. There are many people that are interested in our product and our stock, but they won’t buy the stock because of its sub-penny status.” The goal of the split is to allow Premier Biomedical increased margin between authorized share limits and outstanding shares, and to put the company in a position to permit upward movement of their stock price. As a result of the improved stock price status, potential joint venture partners and major investors are in a position to view joint ventures, partnerships, and investments in a more favorable light. The company's goal is to achieve the status of being an independent, self-financed organization in 2018, and these recent actions will contribute to that goal. “It’s been a long, hard journey,” Hartman said, “but things are really looking up for us with all of our new products, as well as our exciting new intellectual properties.\" For more details on the company, click the link below to hear the rest of the interview. You will also hear more about the company’s international expansion goals, participation in the Sorinex Summer Strong event in May, and efforts to combat opioid addiction. https://upticknewswi...